company background image
IVX

Invion ASX:IVX Stock Report

Last Price

AU$0.009

Market Cap

AU$57.8m

7D

0%

1Y

-50.0%

Updated

29 Jan, 2023

Data

Company Financials

IVX Stock Overview

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia.

IVX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Invion Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Invion
Historical stock prices
Current Share PriceAU$0.009
52 Week HighAU$0.019
52 Week LowAU$0.008
Beta1.1
1 Month Change0%
3 Month Change-10.00%
1 Year Change-50.00%
3 Year Change-25.00%
5 Year Change-40.00%
Change since IPO-97.72%

Recent News & Updates

Is Invion (ASX:IVX) In A Good Position To Invest In Growth?

Dec 08
Is Invion (ASX:IVX) In A Good Position To Invest In Growth?

Recent updates

Is Invion (ASX:IVX) In A Good Position To Invest In Growth?

Dec 08
Is Invion (ASX:IVX) In A Good Position To Invest In Growth?

We're Not Very Worried About Invion's (ASX:IVX) Cash Burn Rate

Aug 16
We're Not Very Worried About Invion's (ASX:IVX) Cash Burn Rate

A Look At The Fair Value Of Invion Limited (ASX:IVX)

Nov 04
A Look At The Fair Value Of Invion Limited (ASX:IVX)

Estimating The Intrinsic Value Of Invion Limited (ASX:IVX)

Mar 23
Estimating The Intrinsic Value Of Invion Limited (ASX:IVX)

We Think Invion (ASX:IVX) Can Easily Afford To Drive Business Growth

Nov 26
We Think Invion (ASX:IVX) Can Easily Afford To Drive Business Growth

Shareholder Returns

IVXAU PharmaceuticalsAU Market
7D0%-4.4%0.6%
1Y-50.0%-25.2%3.5%

Return vs Industry: IVX underperformed the Australian Pharmaceuticals industry which returned -25.2% over the past year.

Return vs Market: IVX underperformed the Australian Market which returned 3.5% over the past year.

Price Volatility

Is IVX's price volatile compared to industry and market?
IVX volatility
IVX Average Weekly Movement12.3%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.5%

Stable Share Price: IVX is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: IVX's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2000n/aThian Chewhttps://www.inviongroup.com

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion’s IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer.

Invion Limited Fundamentals Summary

How do Invion's earnings and revenue compare to its market cap?
IVX fundamental statistics
Market CapAU$57.78m
Earnings (TTM)-AU$2.24m
Revenue (TTM)AU$3.29m

17.6x

P/S Ratio

-25.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IVX income statement (TTM)
RevenueAU$3.29m
Cost of RevenueAU$2.32m
Gross ProfitAU$969.12k
Other ExpensesAU$3.21m
Earnings-AU$2.24m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.00035
Gross Margin29.44%
Net Profit Margin-68.09%
Debt/Equity Ratio0%

How did IVX perform over the long term?

See historical performance and comparison